LSE - Delayed Quote GBp
Aptamer Group PLC (APTA.L)
0.3850
0.0000
(0.00%)
At close: May 2 at 3:58:01 PM GMT+1
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 328.34M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
Dowgate Group Ltd. -- | -- | Direct | -- | Feb 20, 2025 |
Sykes (Tim) -- | Bought at price 0.00 per share. | Direct | -- | Feb 3, 2025 |
Sykes (Tim) -- | Bought at price 0.00 per share. | Direct | -- | Jan 13, 2025 |
Dowgate Group Ltd. -- | -- | Direct | -- | Dec 23, 2024 |
Bunka (David Harry John) -- | Bought at price 0.00 per share. | Direct | -- | Dec 19, 2024 |
Dowgate Group Ltd. -- | -- | Direct | -- | Dec 16, 2024 |
Sykes (Tim) -- | Bought at price 0.00 per share. | Direct | -- | Dec 16, 2024 |
Hargreaves (Adam) -- | Bought at price 0.00 per share. | Direct | -- | Dec 9, 2024 |
Tolley (Arron Craig) -- | Bought at price 0.00 per share. | Direct | -- | Dec 9, 2024 |
Bunka (David Harry John) -- | -- | Direct | -- | Oct 21, 2024 |
Fielding (Dean Andrew) -- | -- | Direct | -- | Oct 21, 2024 |
Hargreaves (Adam) -- | -- | Direct | -- | Oct 21, 2024 |
Hull (Stephen) -- | -- | Direct | -- | Oct 21, 2024 |
Tolley (Arron Craig) -- | -- | Direct | -- | Oct 21, 2024 |
Crux Asset Management Limited -- | -- | Direct | -- | Oct 3, 2024 |
Dowgate Group Ltd. -- | -- | Direct | -- | Oct 3, 2024 |
Slater (Nicholas) -- | -- | Direct | -- | Oct 3, 2024 |
Slater (Nicholas) -- | -- | Direct | -- | Aug 14, 2024 |
Crux Asset Management Limited -- | -- | Direct | -- | Aug 13, 2024 |
Dowgate Group Ltd. -- | -- | Direct | -- | Aug 13, 2024 |
Bunka (David Harry John) -- | -- | Direct | -- | Jun 30, 2024 |
Fielding (Dean Andrew) -- | -- | Direct | -- | Jun 30, 2024 |
Hargreaves (Adam) -- | -- | Direct | -- | Jun 30, 2024 |
Hull (Stephen) -- | -- | Direct | -- | Jun 30, 2024 |
Tolley (Arron Craig) -- | -- | Direct | -- | Jun 30, 2024 |
Slater (Nicholas) -- | -- | Direct | -- | May 29, 2024 |
Chari (s) -- | -- | Direct | -- | May 28, 2024 |
Slater (Nicholas) -- | -- | Direct | -- | Apr 25, 2024 |
Chari (s) -- | -- | Direct | -- | Apr 23, 2024 |
Slater (Nicholas) -- | -- | Direct | -- | Apr 22, 2024 |
Chari (s) -- | -- | Direct | -- | Apr 18, 2024 |
Chari (s) -- | -- | Direct | -- | Mar 28, 2024 |
Spreadex, Ltd. -- | -- | Direct | -- | Jan 3, 2024 |
Tolley (Arron Craig) -- | -- | Direct | -- | Oct 31, 2023 |
Bunka (David Harry John) -- | -- | Direct | -- | Oct 12, 2023 |
Fielding (Dean Andrew) -- | -- | Direct | -- | Oct 12, 2023 |
Hargreaves (Adam) -- | -- | Direct | -- | Oct 12, 2023 |
Hull (Stephen) -- | -- | Direct | -- | Oct 12, 2023 |
Tolley (Arron Craig) -- | -- | Direct | -- | Oct 12, 2023 |
Hargreaves (Adam) -- | Bought at price 0.01 per share. | Direct | 60,000 | Sep 25, 2023 |
Slater (Nicholas) -- | -- | Direct | -- | Sep 25, 2023 |
Bunka (David Harry John) -- | -- | Direct | -- | Sep 19, 2023 |
Spreadex, Ltd. -- | -- | Direct | -- | Sep 12, 2023 |
Cantor Fitzgerald Europe -- | -- | Direct | -- | Aug 24, 2023 |
Amati Global Investors, Ltd. -- | -- | Direct | -- | Aug 21, 2023 |
Bunka (David Harry John) -- | Bought at price 0.01 per share. | Direct | 13,000 | Aug 21, 2023 |
Fielding (Dean Andrew) -- | Bought at price 0.01 per share. | Direct | 19,370 | Aug 21, 2023 |
Fleming (Alastair) -- | Bought at price 0.01 per share. | Direct | 6,500 | Aug 21, 2023 |
Gilham (Ian David) -- | Bought at price 0.01 per share. | Direct | 26,000 | Aug 21, 2023 |
Hargreaves (Adam) -- | Bought at price 0.01 per share. | Direct | 227,500 | Aug 21, 2023 |
Related Tickers
PYC.L Physiomics Plc
0.4200
-1.18%
CIZ.L Cizzle Biotechnology Holdings Plc
1.5500
0.00%
GENF.L Genflow Biosciences plc
0.8750
-14.63%
BSFA.L BSF Enterprise Plc
3.1250
-5.30%
NFX.L Nuformix plc
0.1250
-5.66%
OXB.L Oxford Biomedica plc
295.00
0.00%
ACTU Actuate Therapeutics, Inc. Common stock
9.76
-7.31%
ENSC Ensysce Biosciences, Inc.
2.4800
-3.50%
CRSP CRISPR Therapeutics AG
37.78
-1.23%